Corrigendum: Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Jinlida Granules on Metabolic Syndrome in Patients With Abnormal Glucose Metabolism

Front Endocrinol (Lausanne). 2020 Sep 3:11:649. doi: 10.3389/fendo.2020.00649. eCollection 2020.

De Jin¹, Lili Hou², Shuolong Han², Liping Chang³, Huailin Gao^{4

5}, Yiru Zhao¹, Shenghui Zhao¹, Xuedong An¹, Guangyao Song⁶, Chunli Piao⁷, Fengmei Lian¹, Tong Xiao-Lin¹, Zhenhua Jia^{2

3

4

5}

¹ Department of Endocrinology, Guang'anmen Hospital of China Academy of Chinese Medical Science, Beijing, China.
² Department of Cardiovascularology, Key Laboratory of State Administration of TCM (Cardio-Cerebral Vessel Collateral Disease), Shijiazhuang, China.
³ Department of Cardiovascularology, National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Shijiazhuang, China.
⁴ Department of Cardiovascularology, Key Disciplines of State Administration of TCM for Collateral Disease, Shijiazhuang, China.
⁵ National Administration of Traditional Chinese Medicine (TCM) Regional TCM Diagnosis and Treatment Center (Cardiovascular Disease), Shijiazhuang, China.
⁶ Department of Endocrinology, Heibei Yiling Hospital, Shijiazhuang, China.
⁷ Guangzhou University of Traditional Chinese Medicine, Shenzhen Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.

Abstract

[This corrects the article DOI: 10.3389/fendo.2020.00415.].

Keywords: Chinese medicine; Jinlida granules; abnormal glucose metabolism; clinical trial; metabolic syndrome.